CDC Committee Votes to Recommend Novavax Vaccine

President’s administration promotes continued COVID-19 vaccination.

A Centers for Disease Control advisory committee unanimously voted this past week to recommend the Novavax vaccine for COVID-19. Though it is not approved as a booster shot and only as a preliminary dose, the Novavax COVID-19 vaccine uses modified proteins of the coronavirus itself rather than mRNA technology. The advisors hope that those hesitant to get vaccinated benefit from having a different vaccine to choose from for themselves.

“While more than two-thirds of the American public are already fully vaccinated, we must maintain a sense of urgency to ensure all eligible individuals get vaccinated, particularly heading into the Fall,” said Jason Roos of the Department of Health and Human Services. “This latest vaccine would offer people another choice to help protect themselves from severe disease or hospitalization caused by COVID-19,” he added.  

As the Lord Leads, Pray with Us…

  • For guidance for Director Walensky as she heads the CDC.
  • For the Lord to direct Secretary Becerra as he oversees the agencies under the Department of Health and Human Services.
  • For wisdom for Commissioner Califf as the FDA tests, reviews, and authorizes therapies and vaccines.

Sources: The Hill, Reuters


Back to top